Publicaciones científicas
Adjuvant therapy for colon cancer: genes, genes... and the patient in the center
20-abr-2018
| Revista: Clinical Cancer Research
Rodriguez J (1), Vicent S (2), Chopitea A (1), Ponz-Sarvise M (3).
RESUMEN
Although molecular subtype-based stratification and genomic signatures of increasing complexity are becoming a new strategy to guide therapeutic decisions in stage II/III colon cancer, several prognostic factors that can be easily obtained from FFPE specimens should be considered in order to create combined models that better define individual patients needs.
CITA DEL ARTÍCULO Clin Cancer Res. 2018 Apr 20. pii: clincanres.0818.2018. doi: 10.1158/1078-0432.CCR-18-0818
Nuestros autores
Investigador | Investigador principal
Grupo de Investigación en Oncogenes y Dianas Efectoras